Kare Schultz - Mar 4, 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: President and CEO, Director
Signature: /s/ Dov Bergwerk as attorney-in-fact for Kare Schultz
Stock symbol: TEVA
Transactions as of: Mar 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/8/2022, 03:12 PM
Previous filing: Mar 2, 2022
Next filing: May 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+59.7K	+5.27%		1.19M	Mar 4, 2022	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+163K	+13.64%		1.35M	Mar 4, 2022	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+71.3K	+5.26%		1.43M	Mar 5, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-59.7K	-50%	$0.00	59.7K	Mar 4, 2022	Ordinary Shares	59.7K		Direct	F1, F2, F3
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-163K	-100%	$0.00^*	0	Mar 4, 2022	Ordinary Shares	163K		Direct	F1, F2, F4
transaction	TEVA	Restricted Share Units	Award	$0	+402K		$0.00	402K	Mar 4, 2022	Ordinary Shares	402K		Direct	F1, F2, F5
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-71.3K	-25%	$0.00	214K	Mar 5, 2022	Ordinary Shares	71.3K		Direct	F1, F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Restricted share units were granted on March 4, 2019, with 59,701 having vested on each of March 4, 2021 and March 4, 2022 and 59,702 vesting on March 4, 2023.
F4	Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F5	Restricted share units were granted on March 4, 2022, with 100,536 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
F6	Restricted share units were granted on March 5, 2021, with 71,292 having vested on March 5, 2022, 71,292 vesting on each of March 5, 2023 and March 5, 2024, and 71,295 vesting on March 5, 2025.